Platelet polymorphisms

Platelets, Second Edition

Volumn , Issue , 2006, Pages 281-307

  Afshar Kharghan, Vahid ^a   Vijayan, K Vinod ^a   Bray, Paul F ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85148830906     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369367-9/50776-X     Document Type: Chapter

References (341)

1. A.E. von dem Borne and F. Decary (1990) ICSH/ISBT Working Party on platelet serology. Nomenclature of platelet-specific antigens. Vox Sang 58 176.
2. P.J. Newman (1994) Nomenclature of human platelet alloantigens: A problem with the HPA system? Blood 83 1447-1451.
3. M. Cargill, D. Altshuler, J. Ireland, et al. (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genet 22 231-238.
4. M.K. Halushka, J.B. Fan, K. Bentley, et al. (1999) Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 22 239-247.
5. P.J. Di Paola J., A. Jugessur, T. Goldman, et al. (2005) Platelet glycoprotein Ibalpha and integrin alphabeta polymorphisms: Gene frequencies and linkage disequilibrium in a population diversity panel. J Thromb Haemost 3 1511-1521.
6. D.R. Phillips, I.F. Charo, L.V. Parise, et al. (1988) The platelet membrane glycoprotein IIb-IIIa complex. Blood 71 831-843.
7. P.F. Bray and M.A. Shuman (1990) Identification of an abnormal gene for the GPIIIa subunit of the platelet fibrinogen receptor resulting in Glanzmann's thrombasthenia. Blood 75 881-888.
8. A.T. Nurden (1999) Inherited abnormalities of platelets. Thromb Haemost 82 468-480.
9. P.F. Bray, J.P. Rosa, G.I. Johnston, et al. (1987) Platelet glycoprotein IIb. Chromosomal localization and tissue expression. J Clin Invest 80 1812-1817.
10. A.B. Zimrin, S. Gidwitz, S. Lord, et al. (1990) The genomic organization of platelet glycoprotein IIIa. J Biol Chem 265 8590-8595.
11. C.C. Wilhide, Y. Jin, Q. Guo, et al. (1997) The human integrin b3 gene is 63 kb and contains a 5.-UTR sequence regulating expression. Blood 90 3951-3961.
12. M. Villa-Garcia, L. Li, G. Riely, et al. (1994) Isolation and characterization of a TATA-less promoter for the human b3 integrin gene. Blood 83 668-676.
13. P.J. Newman, J.G. McFarland and R.H. Aster (1998) The alloimmune thrombocytopenias. J. Loscalzo, A.I. Schafer (Eds) Thrombosis and hemorrhage Baltimore, MD: Williams & Wilkins 599-615.
14. T.J. Kunicki and R.H. Aster (1979) Isolation and immunologic characterization of the human platelet alloantigen, P1A1. Mol Immunol 16 353-360.
15. P.J. Newman, L.S. Martin, M.A. Knipp, et al. (1985) Studies on the nature of the human platelet alloantigen, PlA1: Localization to a 17,000-dalton polypeptide. Mol Immunol 22 719-729.
16. L.A. Fitzgerald, B. Steiner, S.C. Rall, et al. (1987) Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone Identity with platelet glycoprotein IIIa and similarity to “integrin”. J Biol Chem 262 3936-3939.
17. J.P. Rosa, P.F. Bray, O. Gayet, et al. (1988) Cloning of glycoprotein IIIa cDNA from human erythroleukemia cells and localization of the gene to chromosome 17. Blood 72 593-600.
18. P.J. Newman, R.S. Derbes and R.H. Aster (1989) The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 83 1778-1781.
19. K. Unkelbach, R. Kalb, C. Breitfeld, et al. (1994) New polymorphism on platelet glycoprotein IIIa gene recognized by endonuclease Msp I: Implications for PlA typing by allele-specific restriction analysis. Transfusion 34 592-595.
20. S. Walchshofer, D. Ghali, M. Fink, et al. (1994) A rare leucine40/arginine40 polymorphism on platelet glycoprotein IIIa is linked to the human platelet antigen 1b. Vox Sang 67 231-234.
21. F. Flug, R. Espinola, L.X. Liu, et al. (1991) A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not defi ne the PlA1 epitope. Blood 77 1964-1969.
22. N. Valentin, G.P. Visentin and P.J. Newman (1995) Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: Evidence for heterogeneity in the humoral response. Blood 85 3028-3033.
23. E.F. van Leeuwen, O.C. Leeksma, J.A. Van Mourik, et al. (1984) Effect of the binding of anti-Zwa antibodies on platelet function. Vox Sang 47 280-289.
24. T.J. Kunicki (1989) Biochemistry of platelet-associated isoantigens and alloantigens. T.J. Kunicki, J.N. George (Eds) Platelet immunobiology: Molecular and clinical aspects Philadelphia, PA: Lippincott 99-120.
25. S.E. D'Souza, M.H. Ginsberg, T.A. Burke, et al. (1988) Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science 242 91-93.
26. I.F. Charo, L. Nannizzi, D.R. Phillips, et al. (1991) Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide. J Biol Chem 266 1415-1421.
27. P. Bork, T. Doerks, T.A. Springer, et al. (1999) Domains in plexins: Links to integrins and transcription factors. Trends Biochem Sci 24 261-263.
28. Q. Zang and T.A. Springer (2001) Amino acid residues in the PSI domain and cysteine-rich repeats of the integrin b2 subunit that restrain activation of the integrin aXb2. J Biol Chem 276 6922-6929.
29. D. Feng, K. Lindpaintner, M.G. Larson, et al. (1999) Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 19 1142-1147.
30. A.D. Michelson, M.I. Furman, P. Goldschmidt-Clermont, et al. (2000) Platelet GP IIIa PlA polymorphisms display different sensitivities to agonists. Circulation 101 1013-1018.
31. A. Szczeklik, A. Undas, M. Sanak, et al. (2000) Short report: Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 110 965-967.
32. D. Lasne, M. Krenn, V. Pingault, et al. (1997) Interdonor variability of platelet response to thrombin receptor activation: Influence of PlA2 polymorphism. Br J Haematol 99 801-807.
33. A.H. Goodall, N. Curzen, M. Panesar, et al. (1999) Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. Eur Heart J 20 742-747.
34. D.J. Meiklejohn, S.J. Urbaniak and M. Greaves (1999) Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2) : No association with platelet fibrinogen binding. Br J Haematol 105 664-666.
35. G. Andrioli, P. Minuz, P. Solero, et al. (2000) Defective platelet response to arachidonic acid and thromboxane A2 in subjects with PlA2 polymorphism of b3 subunit (glycoprotein IIIa). Br. J Haematol 110 911-918.
36. K.V. Vijayan, P.J. Goldschmidt-Clermont, C. Roos, et al. (2000) The PlA2 polymorphism of integrin b3 enhances outside-in signaling and adhesive functions. J Clin Invest 105 793-802.
37. M. Sajid, K.V. Vijayan, S. Souza, et al. (2002) PlA polymorphism of integrin b3 differentially modulates cellular migration on extracellular matrix proteins. Arterioscler Thromb Vasc Biol 22 1984-1989.
38. K.V. Vijayan, Y. Liu, J.F. Dong, et al. (2003) Enhanced activation of mitogen-activated protein kinase and myosin light chain kinase by the Pro33 polymorphism of integrin b3. J Biol Chem 278 3860-3867.
39. K.V. Vijayan, Y. Liu, W. Sun, et al. (2005) The Pro33 isoform of integrin β3 enhances outside-in signaling in human platelets by regulating the activation of serine/threonine phosphatases. J Biol Chem 280 21756-21762.
40. K.V. Vijayan, T.C. Huang, Y. Liu, et al. (2003) Shear stress augments the enhanced adhesive phenotype of cells expressing the Pro33 isoform of integrin beta3. FEBS Lett 540 41-46.
41. K. Furihata, D.J. Nugent, A. Bissonette, et al. (1987) On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. J Clin Invest 80 1624-1630.
42. J.M. Friedman and R.H. Aster (1985) Neonatal alloimmune thrombocytopenic purpura and congenital porencephaly in two siblings associated with a “new” maternal antiplatelet antibody. Blood 65 1412-1415.
43. Y. Shibata, T. Miyaji, Y. Ichikawa, et al. (1986) A new platelet antigen system, Yuka/Yukb. Vox Sang 51 334-336.
44. T.L. Simon, J. Collins, T.J. Kunicki, et al. (1988) Posttransfusion purpura associated with alloantibody specific for the platelet antigen, Pena. Am J Hematol 29 38-40.
45. R. Wang, K. Furihata, J.G. McFarland, et al. (1992) An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system. J Clin Invest 90 2038-2043.
46. S. Tanaka, S. Ohnoki, H. Shibata, et al. (1996) Gene frequencies of human platelet antigens on glycoprotein IIIa in Japanese. Transfusion 36 813-817.
47. D.H. Seo, S.S. Park, D.W. Kim, et al. (1998) Gene frequencies of eight human platelet-specific antigens in Koreans. Transfus Med 8 129-132.
48. R.W. Kuijpers, S. Simsek, N.M. Faber, et al. (1993) Single point mutation in human glycoprotein IIIa is associated with a new platelet-specific alloantigen (Mo) involved in neonatal alloimmune thrombocytopenia. Blood 81 70-76.
49. J.G. McFarland, V. Blanchette, J. Collins, et al. (1993) Neonatal alloimmune thrombocytopenia due to a new platelet-specific alloantibody. Blood 81 3318-3323.
50. H. Kroll, V. Kiefel, S. Santoso, et al. (1990) Sra, a private platelet antigen on glycoprotein IIIa associated with neonatal alloimmune thrombocytopenia. Blood 76 2296-2302.
51. V. Jallu, M. Meunier, M. Brement, et al. (2002) A new platelet polymorphism Duv (a+) , localized within the RGD binding domain of glycoprotein IIIa, is associated with neonatal thrombocytopenia. Blood 99 4449-4456.
52. S. Santoso, R. Kalb, H. Kroll, et al. (1994) A point mutation leads to an unpaired cysteine residue and a molecular weight polymorphism of a functional platelet b3 integrin subunit. The Sra alloantigen system of GPIIIa. J Biol Chem 269 8439-8444.
53. R. Wang, J.G. McFarland, R. Kekomaki, et al. (1993) Amino acid 489 is encoded by a mutational “hot spot” on the b3 integrin chain: The CA/TU human platelet alloantigen system. Blood 82 3386-3391.
54. S. Tanaka, A. Taniue, N. Nagao, et al. (1996) Genotype frequencies of the human platelet antigen, Ca/Tu, in Japanese, determined by a PCR-RFLP method. Vox Sang 70 40-44.
55. O. Peyruchaud, F. Bourre, M.C. Morel-Kopp, et al. (1997) HPA-10w (b) (Laa) : Genetic determination of a new plateletspecifi c alloantigen on glycoprotein IIIa and its expression in COS-7 cells. Blood 89 2422-2428.
56. S. Simsek, C. Folman, C.E. van der Schoot, et al. (1997) The Arg633His substitution responsible for the private platelet antigen Groa unravelled by SSCP analysis and direct sequencing. Br J Haematol 97 330-335.
57. C.L. Wagner, M.A. Mascelli, D.S. Neblock, et al. (1996) Analysis of GPIIb/IIIa receptor number by quantifi cation of 7E3 binding to human platelets. Blood 88 907-914.
58. P.F. Bray, J.-P. Rosa, V.R. Lingappa, et al. (1986) Biogenesis of the platelet receptor for fibrinogen: Evidence for separate precursors for glycoproteins IIb and IIIa. Proc Natl Acad Sci USA 83 1480-1484.
59. R. Heidenreich, R. Eisman, S. Surrey, et al. (1990) Organization of the gene for platelet glycoprotein IIb. Biochemistry 29 1232-1244.
60. A.E. von dem Borne, E. von Riesz, F.W. Verheugt, et al. (1980) Baka, a new platelet-specific antigen involved in neonatal allo-immune thrombocytopenia. Vox Sang 39 113-120.
61. R.M. Keimowitz, J. Collins, K. Davis, et al. (1986) Posttransfusion purpura associated with alloimmunization against the platelet-specific antigen, Baka. Am J Hematol 21 79-88.
62. T.S. Kickler, J.H. Herman, K. Furihata, et al. (1988) Identification of Bakb, a new platelet-specific antigen associated with posttransfusion purpura. Blood 71 894-898.
63. C.E. van der Schoot, M. Wester, A.E. dem Borne, et al. (1986) Characterization of platelet-specific alloantigens by immunoblotting: Localization of Zw and Bak antigens. Br J Haematol 64 715-723.
64. S.J. Letellier, J.B. Hunter and R.H. Aster (1988) Probable genetic linkage between genes coding for platelet-specific antigens of the PlA and Bak systems. Am J Hematol 29 139-143.
65. P.F. Bray, G. Barsh, J.P. Rosa, et al. (1988) Physical linkage of the genes for platelet membrane glycoproteins IIb and IIIa. Proc Natl Acad Sci USA 85 8683-8687.
66. M.A. Thornton, M. Poncz, M. Korostishevsky, et al. (1999) The human platelet alphaIIb gene is not closely linked to its integrin partner beta3. Blood 94 2039-2047.
67. S. Lyman, R.H. Aster, G.P. Visentin, et al. (1990) Polymorphism of human platelet membrane glycoprotein IIb associated with the Baka/Bakb alloantigen system. Blood 75 2343-2348.
68. A. Goldberger, M. Kolodziej, M. Poncz, et al. (1991) Effect of single amino acid substitutions on the formation of the PlA and Bak alloantigenic epi topes. Blood 78 681-687.
69. J. Ruan, O. Peyruchaud, A. Nurden, et al. (1998) Linkage of four polymorphisms on the aIIb gene. Br J Haematol 102 622-625.
70. H. Take, Y. Tomiyama, Y. Shibata, et al. (1990) Demonstration of the heterogeneity of epitopes of the platelet-specifi c alloantigen, Baka. Br J Haematol 76 395-400.
71. I. Djaffar, D. Vilette, D. Pidard, et al. (1993) Human platelet antigen 3 (HPA-3) : Localization of the determinant of the alloantibody Leka (HPA-3a) to the C-terminus of platelet glycoprotein IIb heavy chain and contribution of O-linked carbohydrates. Thromb Haemost 69 485-489.
72. P. Noris, S. Simsek, L.G. Bruijne-Admiraal, et al. (1995) Maxa, a new low-frequency platelet-specific antigen localized on glycoprotein IIb, is associated with neonatal alloimmune thrombocytopenia. Blood 86 1019-1026.
73. J.A. López and J.F. Dong (1997) Structure and function of the glycoprotein Ib-IX-V complex. Curr Opin Hematol 4 323-329.
74. R.H. Wenger, A.N. Wicki, N. Kieffer, et al. (1989) The 5 flanking region and chromosomal localization of the gene encoding human platelet membrane glycoprotein Iba. Gene 85 517-524.
75. M.D. Kelly, D.W. Essex, S.S. Shapiro, et al. (1994) Complementary DNA cloning of the alternatively expressed endothelial cell glycoprotein Ibb (GPIbb) and localization of the GPIbb gene to chromosome 22. J Clin Invest 93 2417-2424.
76. M. Yagi, S. Edelhoff, C.M. Disteche, et al. (1995) Human platelet glycoproteins V and IX: Mapping of two leucine-rich glycoprotein genes to chromosome 3 and analysis of structures. Biochemistry 34 16132-16137.
77. B.J. Fredrickson, J.F. Dong, L.V. McIntire, et al. (1998) Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood 92 3684-3693.
78. R.W.A.M. Kuijpers, N.M. Faber, H.T.M. Cuypers, et al. (1992) NH2-terminal globular domain of human platelet glycoprotein Iba has a methionine145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 89 381-384.
79. M. Murata, K. Furihata, F. Ishida, et al. (1992) Genetic and structural characterization of an amino acid dimorphism in glycoprotein Iba involved in platelet transfusion refractoriness. Blood 79 3086-3090.
80. H. Saji, E. Maruya, H. Fujii, et al. (1989) New platelet antigen, Siba, involved in platelet transfusion refractoriness in a Japanese man. Vox Sang 56 283-287.
81. N. Bizzaro and G. Dianese (1988) Neonatal alloimmune amegakaryocytosis. Case report. Vox Sang 54 112-114.
82. F. Ishida, H. Saji, E. Maruya, et al. (1991) Human plateletspecifi c antigen, Siba, is associated with the molecular weight polymorphism of glycoprotein Iba. Blood 78 1722-1729.
83. R.W. Kuijpers, W.H. Ouwehand, P.M. Bleeker, et al. (1992) Localization of the platelet-specific HPA-2 (Ko) alloantigens on the N-terminal globular fragment of platelet glycoprotein Iba. Blood 79 283-288.
84. H. Ulrichts, K. Vanhoorelbeke, S. Cauwenberghs, et al. (2003) von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism. Arterioscler Thromb Vasc Biol 23 1302-1307.
85. C.Q. Li, S.F. Garner, J. Davies, et al. (2000) Threonine-145/Methionine-145 variants of baculovirus produced recombinant ligand binding domain of GPIba express HPA-2 epitopes and show equal binding of von Willebrand factor. Blood 95 205-211.
86. M. Mazzucato, P. Pradella, A. de, et al. (1996) Frequency and functional relevance of genetic threonine145/methionine145 dimorphism in platelet glycoprotein Iba in an Italian population. Transfusion 36 891-894.
87. Y. Matsubara, M. Murata, T. Hayashi, et al. (2005) Platelet glycoprotein Iba polymorphisms affect the interaction with von Willebrand factor under flow conditions. Br J Haematol 128 533-539.
88. M. Moroi, S.M. Jung and N. Yoshida (1984) Genetic polymorphism of platelet glycoprotein Ib. Blood 64 622-629.
89. J.A. López, E.H. Ludwig and B.J. McCarthy (1992) Polymorphism of human glycoprotein Iba results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications. J Biol Chem 267 10055-10061.
90. F. Ishida, K. Furihata, K. Ishida, et al. (1995) The largest variant of platelet glycoprotein Iba has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine 145. Blood 86 1357-1360.
91. M.C. Ozelo, D.S. Costa, L.H. Siqueira, et al. (2004) Genetic variability of platelet glycoprotein Iba gene. Am J Hematol 77 107-116.
92. K.M. Aramaki and A.P. Reiner (1999) A novel isoform of platelet glycoprotein Iba is prevalent in African Americans. Am J Hematol 60 77-79.
93. J. Corral, R. Gonzalez-Conejero, M.L. Lozano, et al. (1998) New alleles of the platelet glycoprotein Iba gene. Br J Haematol 103 997-1003.
94. F. Ishida, T. Ito, M. Takei, et al. (2000) Genetic linkage of Kozak sequence polymorphism of the platelet glycoprotein Iba with human platelet antigen-2 and variable number of tandem repeat polymorphism, and its relationship with coronary artery disease. Br J Haematol 111 1247-1249.
95. S. Kaski, R. Kekomäki and J. Partanen (1996) Systematic screening for genetic po lymorphism in human platelet glycoprotein Iba. Immunogenetics 44 170-176.
96. M.B. Frank, A.P. Reiner, S.M. Schwartz, et al. (2001) The Kozak sequence polymorphism of platelet glycoprotein Iba and risk of nonfatal myocardial infarction and nonfatal stroke in young women. Blood 97 875-879.
97. M. Kozak (1981) Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Res 9 5233-5262.
98. M. Kozak (1984) Point mutations close to the AUG initiator codon affect the effi ciency of translation of rat preproinsulin in vivo. Nature 308 241-246.
99. M. Kozak (1987) At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 196 947-950.
100. V. Afshar-Kharghan, C.Q. Li, M. Khoshnevis-Asl, et al. (1999) Kozak sequence polymorphism of the glycoprotein (GP) Iba gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood 94 186-191.
101. J. Corral, M.L. Lozano, R. Gonzalez-Conejero, et al. (2000) A common polymorphism flanking the ATG initiator codon of GPIba does not affect expression and is not a major risk factor for arterial thrombosis. Thromb Haemost 83 23-28.
102. P. Jilma-Stohlawetz, M. Homoncik, B. Jilma, et al. (2003) Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates. Br J Haematol 120 652-655.
103. S. Santoso, P. Zimmermann, U.J. Sachs, et al. (2002) The impact of the Kozak sequence polymorphism of the glycoprotein Iba gene on the risk and extent of coronary heart disease. Thromb Haemost 87 345-346.
104. Y. Cadroy, K.S. Sakariassen, J.P. Charlet, et al. (2001) Role of four platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men. Blood 98 3159-3161.
105. J.A. López, S. Weisman, D.A. Sanan, et al. (1994) Glycoprotein (GP) Ibb is the critical subunit linking GP Iba and GP IX in the GP Ib-IX complex. Analysis of partial complexes. J Biol Chem 269 23716-23721.
106. M. Yagi, S. Edelhoff, C.M. Disteche, et al. (1994) Structural characterization and chromosomal location of the gene encoding human platelet glycoprotein Ibb. J Biol Chem 269 17424-17427.
107. J.A. Lopez, D.W. Chung, K. Fujikawa, et al. (1988) The a and b chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci USA 85 2135-2139.
108. V. Kiefel, M. Vicariot, Y. Giovangrandi, et al. (1995) Alloimmunization against Iy, a low-frequency antigen on platelet glycoprotein Ib/IX as a cause of severe neonatal alloimmune thrombocytopenic purpura. Vox Sang 69 250-254.
109. U.J. Sachs, V. Kiefel, M. Bohringer, et al. (2000) Single amino acid substitution in human platelet glycoprotein Ibb is responsible for the formation of the platelet-specific alloantigen Iya. Blood 95 1849-1855.
110. F. Ishida, T. Ito, S. Santoso, et al. (1999) Low prevalence of a polymorphism of platelet membrane glycoprotein Ibb associated with neonatal alloimmune thrombocytopenic purpura in Asian populations. Int J Hematol 69 54-56.
111. J.A. López, R.K. Andrews, V. Afshar-Kharghan, et al. (1998) Bernard-Soulier Syndrome. Blood 91 4397-4418.
112. C.Q. Li, J.-F. Dong, F. Lanza, et al. (1995) Expression of platelet glycoprotein (GP) V in heterologous cells and evidence for its association with GP Iba in forming a GP Ib-IX-V complex on the cell surface. J Biol Chem 270 16302-16307.
113. M.L. Kahn, T.G. Diacovo, D.F. Bainton, et al. (1999) Glycoprotein V-defi cient platelets have undiminished thrombin responsiveness and do not exhibit a Bernard-Soulier phenotype. Blood 94 4112-4121.
114. J.-F. Dong, G. Sae-Tung and J.A. López (1997) Role of glycoprotein V in the formation of the platelet high affi nity thrombin-binding site. Blood 89 4355-4363.
115. V. Ramakrishnan, P.S. Reeves, F. DeGuzman, et al. (1999) Increased thrombin responsiveness in platelets from mice lacking glycoprotein V. Proc Natl Acad Sci USA 96 13336-13341.
116. V. Ramakrishnan, F. DeGuzman, M. Bao, et al. (2001) A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Proc Natl Acad Sci USA 98 1823-1828.
117. S. Koskela, R. Kekomaki and J. Partanen (1998) Genetic polymorphism in human platelet glycoprotein GP Ib/IX/V complex is enriched in GP V (CD42d). Tissue Antigens 52 236-241.
118. S.P. Watson and J. Gibbins (1998) Collagen receptor signalling in platelets: Extending the role of the ITAM. Immunol Today 19 260-264.
119. Y. Takada and M.E. Hemler (1989) The primary structure of the VLA-2/collagen receptor alpha 2 subunit (platelet GPIa) : Homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol 109 397-407.
120. C. Mueller-Eckhardt, V. Kiefel, A. Grubert, et al. (1989) three hundred and forty-eight cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1 363-366.
121. S. Santoso, V. Kiefel and C. Mueller-Eckhardt (1989) Immunochemical characterization of the new platelet alloantigen system Bra/Brb. Br J Haematol 72 191-198.
122. S. Santoso, R. Kalb, M. Walka, et al. (1993) The human platelet alloantigens Bra and Brb are associated with a single amino acid polymorphism on glycoprotein Ia (integrin subunit a2). J Clin Invest 92 2427-2432.
123. M. Kritzik, B. Savage, D.J. Nugent, et al. (1998) Nucleotide polymorphisms in the a2 gene defi ne multiple alleles that are associated with differences in platelet a2b1 density. Blood 92 2382-2388.
124. T.J. Kunicki, M. Kritzik, D.S. Annis, et al. (1997) Hereditary variation in platelet integrin a2b1 density is associated with two silent polymorphisms in the a2 gene coding sequence. Blood 89 1939-1943.
125. B. Jacquelin, M.D. Tarantino, M. Kritzik, et al. (2001) Allele-dependent transcriptional regulation of the human integrin a2 gene. Blood 97 1721-1726.
126. S. Santoso, J. Amrhein, H.A. Hofmann, et al. (1999) A point mutation Thr799Met on the a2 integrin leads to the formation of new human platelet alloantigen Sita and affects collagen-induced aggregation. Blood 94 4103-4111.
127. J. Corral, R. Gonzalez-Conejero, J. Rivera, et al. (1999) Role of the 807 C/T polymorphism of the a2 gene in platelet GP Ia collagen receptor expression and function —effect in thromboembolic diseases. Thromb Haemost 81 951-956.
128. J. Corral, J. Rivera, R. Gonzalez-Conejero, et al. (1999) The number of platelet glycoprotein Ia molecules is associated with the genetically linked 807 C/T and HPA-5 polymorphisms. Transfusion 39 372-378.
129. M. Roest, J.J. Sixma, Y.P. Wu, et al. (2000) Platelet adhesion to collagen in healthy volunteers is influenced by variation of both a2b1 density and von Willebrand factor. Blood 96 1433-1437.
130. B. Jacquelin, D. Rozenshteyn, S. Kanaji, et al. (2001) Characterization of inherited differences in transcription of the human integrin a2 gene. J Biol Chem 276 23518-23524.
131. Y. Ezumi, T. Uchiyama and H. Takayama (2000) Molecular cloning, genomic structure, chromosomal localization, and alternative splice forms of the platelet collagen receptor glycoprotein VI. Biochem Biophys Res Commun 277 27-36.
132. L. Joutsi-Korhonen, P.A. Smethurst, A. Rankin, et al. (2003) The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood 101 4372-4379.
133. S.A. Croft, N.J. Samani, M.D. Teare, et al. (2001) Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation 104 1459-1463.
134. D. Best, Y.A. Senis, G.E. Jarvis, et al. (2003) GPVI levels in platelets: Relationship to platelet function at high shear. Blood 102 2811-2818.
135. K.R. McCrae, S.J. Shattil and D.B. Cines (1990) Platelet activation induces increased Fcg receptor expression. J Immunol 144 3920-3927.
136. M. King, P. McDermott and A.D. Schreiber (1990) Characterization of the Fcg receptor on human platelets. Cell Immunol 128 462-479.
137. M. Daeron (1997) Fc receptor biology. Annu Rev Immunol 15 203-234.
138. W.J. Tax, H.W. Willems, P.P. Reekers, et al. (1983) Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells. Nature 304 445-447.
139. P.A. Warmerdam, J.G. van de Winkel, E.J. Gosselin, et al. (1990) Molecular basis for a polymorphism of human Fcg receptor II (CD32). J Exp Med 172 19-25.
140. P.A. Warmerdam, J.G. van de Winkel, A. Vlug, et al. (1991) A single amino acid in the second Ig-like domain of the human Fcg receptor II is critical for human IgG2 binding. J Immunol 147 1338-1343.
141. R.J. Looney, C.L. Anderson, D.H. Ryan, et al. (1988) Structural polymorphism of the human platelet Fc gamma receptor. J Immunol 141 2680-2683.
142. J. Chen, J.F. Dong, C. Sun, et al. (2003) Platelet FcgammaRIIA His131Arg polymorphism and platelet function: Antibodies to platelet-bound fibrinogen induce platelet activation. J Thromb Haemost 1 355-362.
143. C.M. Fraser, S. Arakawa, W.R. McCombie, et al. (1989) Cloning, sequence analysis, and permanent expression of a human a2-adrenergic receptor in Chinese hamster ovary cells. Evidence for independent pathways of receptor coupling to adenylate cyclase attenuation and activation. J Biol Chem 264 11754-11761.
144. B.K. Kobilka, H. Matsui, T.S. Kobilka, et al. (1987) Cloning, sequencing, and expression of the gene coding for the human platelet a2-adrenergic receptor. Science 238 650-656.
145. W. Lockette, S. Ghosh, S. Farrow, et al. (1995) Alpha 2-adrenergic receptor gene polymorphism and hypertension in blacks. Am J Hypertens 8 390-394.
146. K. Freeman, S. Farrow, A. Schmaier, et al. (1995) Genetic polymorphism of the a2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans. Am J Hypertens 8 863-869.
147. K.M. Small, S.L. Forbes, K.M. Brown, et al. (2000) An Asn to Lys polymorphism in the third intracellular loop of the human a2A-adrenergic receptor imparts enhanced agonist-promoted Gi coupling. J Biol Chem 275 38518-38523.
148. P. Fontana, A. Dupont, S. Gandrille, et al. (2003) Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 108 989-995.
149. B.K. Jefferson, J.H. Foster, J.J. McCarthy, et al. (2005) Aspirin resistance and a single gene. Am J Cardiol 95 805-808.
150. M. Shimizu, K. Kanazawa, Y. Matsuda, et al. (2003) Serotonin-2A receptor gene polymorphisms are associated with serotonin-induced platelet aggregation. Thromb Res 112 137-142.
151. B.D. Greenberg, T.J. Tolliver, S.J. Huang, et al. (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88 83-87.
152. E.M. Whyte, B.G. Pollock, W.R. Wagner, et al. (2001) Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression. Am J Psychiatry 158 2074-2076.
153. H. Yanai, H. Chiba, H. Fujiwara, et al. (2000) Phenotypegenotype correlation in CD36 defi ciency types I and II. Thromb Haemost 84 436-441.
154. Y. Tomiyama, H. Take, H. Ikeda, et al. (1990) Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV. Blood 75 684-687.
155. N. Yamamoto, H. Ikeda, N.N. Tandon, et al. (1990) A platelet membrane glycoprotein (GP) defi ciency in healthy blood donors. Blood 76 1698-1703.
156. B.R. Curtis and R.H. Aster (1996) Incidence of the Nak (a) -negative platelet phenotype in African Americans is similar to that of Asians. Transfusion 36 331-334.
157. K. Hirano, T. Kuwasako, Y. Nakagawa-Toyama, et al. (2003) Pathophysiology of human genetic CD36 defi ciency. Trends Cardiovasc Med 13 136-141.
158. H. Kashiwagi, Y. Tomiyama, S. Kosugi, et al. (1994) Identifi cation of molecular defects in a subject with type I CD36 defi ciency. Blood 83 3545-3552.
159. H. Kashiwagi, Y. Tomiyama, S. Kosugi, et al. (1995) Family studies of type II CD36 defi cient subjects: Linkage of a CD36 allele to a platelet-specific mRNA expression defect (s) causing type II CD36 defi ciency. Thromb Haemost 74 758-763.
160. H. Kashiwagi, Y. Tomiyama, S. Honda, et al. (1995) Molecular basis of CD36 defi ciency. Evidence that a 478C > T substitution (proline90 > serine) in CD36 cDNA accounts for CD36 defi ciency. J Clin Invest 95 1040-1046.
161. K. Hoebe, P. Georgel, S. Rutschmann, et al. (2005) CD36 is a sensor of diacylglycerides. Nature 433 523-527.
162. L. McKeown, M. Vail, S. Williams, et al. (1994) Platelet adhesion to collagen in individuals lacking glycoprotein IV. Blood 83 2866-2871.
163. N. Yamamoto, N. Akamatsu, H. Yamazaki, et al. (1992) Normal aggregations of glycoprotein IV (CD36) -defi cient platelets from seven healthy Japanese donors. Br J Haematol 81 86-92.
164. B. Kehrel, A. Kronenberg, J. Rauterberg, et al. (1993) Platelets defi cient in glycoprotein IIIb aggregate normally to collagens type I and III but not to collagen type V. Blood 82 3364-3370.
165. N.N. Tandon, C.F. Ockenhouse, N.J. Greco, et al. (1991) Adhesive functions of platelets lacking glycoprotein IV (CD36). Blood 78 2809-2813.
166. M. Diaz-Ricart, N.N. Tandon, M. Carretero, et al. (1993) Platelets lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood. Blood 82 491-496.
167. L. Serghides, T.G. Smith, S.N. Patel, et al. (2003) CD36 and malaria: Friends or foes? Trends Parasitol 19 461-469.
168. S.M. Herrmann, S. Ricard, V. Nicaud, et al. (1998) The P-selectin gene is highly polymorphic: Reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum Mol Genet 7 1277-1284.
169. D.A. Tregouet, S. Barbaux, S. Escolano, et al. (2002) Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 11 2015-2023.
170. S.C. Barbaux, S. Blankenberg, H.J. Rupprecht, et al. (2001) Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Arterioscler Thromb Vasc Biol 21 1668-1673.
171. A.M. Carter, K. Anagnostopoulou, M.W. Mansfield, et al. (2003) Soluble P-selectin levels, P-selectin polymorphisms and cardiovascular disease. J Thromb Haemost 1 1718-1723.
172. M.A. Miller, S.M. Kerry, Y. Dong, et al. (2004) Association between the Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in a multiethnic population in South London. Thromb Haemost 92 1060-1065.
173. J.G. Kelton, J.W. Smith, P. Horsewood, et al. (1990) Gova/b alloantigen system on human platelets. Blood 75 2172-2176.
174. J.E. Berry, C.M. Murphy, G.A. Smith, et al. (2000) Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens. Br J Haematol 110 735-742.
175. J.O. Bordin, J.G. Kelton, M.N. Warner, et al. (1997) Maternal immunization to Gov system alloantigens on human platelets. Transfusion 37 823-828.
176. J.W. Smith, C.P. Hayward, P. Horsewood, et al. (1995) Characterization and localization of the Gova/b alloantigens to the glycosylphosphatidylinositol-anchored protein CDw109 on human platelets. Blood 86 2807-2814.
177. E. Arnaud, V. Nicaud, O. Poirier, et al. (2000) Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism. Arterioscler Thromb Vasc Biol 20 585-592.
178. A. Dupont, P. Fontana, C. Bachelot-Loza, et al. (2003) An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. Blood 101 1833-1840.
179. M.A. Elrayess, K.E. Webb, G.J. Bellingan, et al. (2004) R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with pro-gression of CHD and CHD events. Atherosclerosis 177 127-135.
180. A.R. Moliterno, D.M. Williams, L.I. Gutierrez-Alamillo, et al. (2004) Mpl Baltimore: A thrombopoietin receptor polymorphism associated with thrombocytosis. Proc Natl Acad Sci USA 101 11444-11447.
181. S.M. Zeng, J.C. Murray, J.A. Widness, et al. (2004) Association of single nucleotide polymorphisms in the thrombopoietin-receptor gene, but not the thrombopoietin gene, with differences in platelet count. Am J Hematol 77 12-21.
182. C. Naber, B.L. Hermann, D. Vietzke, et al. (2000) Enhanced epinephrine-induced platelet aggregation in individuals carrying the G protein b3 subunit 825T allele. FEBS Lett 484 199-201.
183. N.V. Narizhneva, V.J. Byers-Ward, M.J. Quinn, et al. (2004) Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction. J Biol Chem 279 21651-21657.
184. N. Faraday, P.J. Goldschmidt-Clermont and P.F. Bray (1997) Gender differences in platelet GPIIb-IIIa activation. Thromb Haemost 77 748-754.
185. K. Rosenkranz, A. Hinney, A. Ziegler, et al. (1998) Systematic mutation screening of the estrogen receptor b gene in probands of different weight extremes: Identification of several genetic variants. J Clin. Endocrinol Metab 83 4524-4527.
186. K. Tsukamoto, S. Inoue, T. Hosoi, et al. (1998) Isolation and radiation hybrid mapping of dinucleotide repeat polymorphism at the human estrogen receptor b locus. J Hum Genet 43 73-74.
187. S. Ogawa, T. Hosoi, M. Shiraki, et al. (2000) Association of estrogen receptor beta gene polymorphism with bone mineral density. Biochem Biophys Res Commun 269 537-541.
188. X.L. Wang, A.S. Sim, R.F. Badenhop, et al. (1996) A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 2 41-45.
189. T. Tsukada, K. Yokoyama, T. Arai, et al. (1998) Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 245 190-193.
190. A.D. Hingorani, C.F. Liang, J. Fatibene, et al. (1999) A common variant of the endothelial nitric oxide synthase (Glu298 > Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100 1515-1520.
191. L.G. Goldfarb, R.B. Petersen, M. Tabaton, et al. (1992) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: Disease phenotype determined by a DNA polymorphism. Science 258 806-808.
192. S.E. Humphries, M. Cook, M. Dubowitz, et al. (1987) Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1 1452-1455.
193. P.J. Harvey, A.M. Keightley, Y.M. Lam, et al. (2000) A single nucleotide polymorphism at nucleotide —1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels. Br J Haematol 109 349-353.
194. A.M. Keightley, Y.M. Lam, J.N. Brady, et al. (1999) Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: Identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood 93 4277-4283.
195. S. Heptinstall, G.P. Mulley, P.M. Taylor, et al. (1980) Platelet-release reaction in myocardial infarction. Br Med J 280 80-81.
196. M.D. Trip, V.M. Cats, F.J. van Capelle, et al. (1990) Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 322 1549-1554.
197. J.F. Martin, P.M. Bath and M.L. Burr (1991) Influence of platelet size on outcome after myocardial infarction. Lancet 338 1409-1411.
198. J.W. Eikelboom, J. Hirsh, J.I. Weitz, et al. (2002) Aspirinresistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105 1650-1655.
199. M.H. Kroll, J.D. Hellums, L.V. McIntire, et al. (1996) Platelets and shear stress. Blood 88 1525-1541.
200. S. Goto, Y. Ikeda, E. Saldivar, et al. (1998) Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 101 479-486.
201. O. Thordarson and S. Fridriksson (1979) Aggregation of deaths from ischaemic heart disease among first and second degree relatives of 108 males and 42 females with myocardial infarction. Acta Med Scand 205 493-500.
202. A.M. Rissanen and E.A. Nikkila (1977) Coronary artery disease and its risk factors in families of young men with angina pectoris and in controls. Br Heart J 39 875-883.
203. J. Slack and K.A. Evans (1966) The increased risk of death from ischaemic heart disease in first degree relatives of 121 men and 96 women with ischaemic heart disease. J Med Genet 3 329-357.
204. G. Rose (1964) Familial patterns in ischaemic heart disease. Br J Prev Soc Med 18 75-80.
205. A.M. Rissanen (1979) Familial occurrence of coronary heart disease: Effect of age at diagnosis. Am J Cardiol 44 60-66.
206. M.E. Marenberg, N. Risch, L.F. Berkman, et al. (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 1041-1046.
207. K. Ber (1982) The genetics of the hyperlipidemias and coronary artery disease. Prog Clin Biol Res 103 111-125. (Pt B)
208. T.I. Sorensen, G.G. Nielsen, P.K. Andersen, et al. (1988) Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 318 727-732.
209. B. Harvald and M. Hauge (1970) Coronary occlusion in twins. Acta Genet Med Gemellol (Roma ) 19 248-250.
210. T. Pastinen, M. Perola, P. Niini, et al. (1998) Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population. Hum Mol Genet 7 1453-1462.
211. C.F. Sing, M.B. Haviland, A.R. Templeton, et al. (1992) Biological complexity and strategies for finding DNA variations responsible for inter-individual variation in risk of a common chronic disease, coronary artery disease. Ann Med 24 539-547.
212. E.J. Weiss, P.F. Bray, M. Tayback, et al. (1996) A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334 1090-1094.
213. E.L. Grove, T.F. Orntoft, J.F. Lassen, et al. (2004) The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction. J Intern Med 255 637-644.
214. A.M. Carter, N. Ossei-Gerning, I.J. Wilson, et al. (1997) Association of the platelet PlA polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bb 448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation 96 1424-1431.
215. R.B. Zotz, B.R. Winkelmann, M. Nauck, et al. (1998) Polymorphism of platelet membrane glycoprotein IIIa: Human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. Thromb Haemost 79 731-735.
216. M. Garcia-Ribes, D. Gonzalez-Lamuno, R. Hernandez-Estefania, et al. (1998) Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis. Thromb Haemost 79 1126-1129.
217. F. Araujo, A. Santos, V. Araujo, et al. (1999) Genetic risk factors in acute coronary disease. Haemostasis 29 212-218.
218. D. Ardissino, P.M. Mannucci, P.A. Merlini, et al. (1999) Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 94 46-51.
219. D.H. Walter, V. Schachinger, M. Elsner, et al. (1997) Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 350 1217-1219.
220. A. Kastrati, A. Schomig, M. Seyfarth, et al. (1999) PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation 99 1005-1010.
221. R.B. Zotz, M. Klein, H.P. Dauben, et al. (2000) Prospective analysis after coronary-artery bypass grafting: Platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death. Thromb Haemost 83 404-407.
222. J. Mikkelsson, M. Perola, P. Laippala, et al. (1999) Glycoprotein IIIa PlA polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. Arterioscler Thromb Vasc Biol 19 2573-2578.
223. J. Mikkelsson, M. Perola, P. Laippala, et al. (2000) Glycoprotein IIIa PlA1/A2 polymorphism and sudden cardiac death. J Am Coll Cardiol 36 1317-1323.
224. P.M. Ridker, C.H. Hennekens, C. Schmitz, et al. (1997) PlA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 349 385-388.
225. S.M. Herrmann, O. Poirier, P. Marques-Vidal, et al. (1997) The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Étude Cas-Temoins de l'Infarctus du Myocarde. Thromb Haemost 77 1179-1181.
226. C.D. Mamotte, F.M. van Bockxmeer and R.R. Taylor (1998) PlA1/A2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty. Am J Cardiol 82 13-16.
227. J. Corral, R. Gonzalez-Conejero, J. Rivera, et al. (1997) HPA-1 genotype in arterial thrombosis —role of HPA-1b polymorphism in platelet function. Blood Coagul Fibrinolysis 8 284-290.
228. S. Kekomaki, L. Hamalainen, R. Kauppinen-Makelin, et al. (1999) Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischaemic stroke. J Cardiovasc Risk 6 1317.
229. J.L. Anderson, G.J. King, T.L. Bair, et al. (1999) Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease. J Am Coll Cardiol 33 727-733.
230. W.C. Hooper, C. Lally, H. Austin, et al. (1999) The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest 116 880-886.
231. M. Laule, I. Cascorbi, V. Stangl, et al. (1999) A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: A casecontrolled study. Lancet 353 708-712.
232. N. Aleksic, H. Juneja, A.R. Folsom, et al. (2000) Platelet PlA2 allele and incidence of coronary heart disease: Results from the Atherosclerosis Risk In Communities (ARIC) Study. Circulation 102 1901-1905.
233. L.R. Cardon and J.I. Bell (2001) Association study designs for complex diseases. Nature Rev Genet 2 91-99.
234. N.H. Lopes, A.C. Pereira, W. Hueb, et al. (2004) Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking. Am J Cardiol 93 1469-1472.
235. S.M. Boekholdt, R.J. Peters, M.P. de Maat, et al. (2004) Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular events. Am Heart J 147 181-186.
236. E. Durante-Mangoni, G.J. Davies, N. Ahmed, et al. (1998) Coronary thrombosis and the platelet glycoprotein IIIA gene PlA2 polymorphism. Thromb Haemost 80 218-219.
237. A. Gardemann, J. Humme, J. Stricker, et al. (1998) Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients. Thromb Haemost 80 214-217.
238. C. Bottiger, A. Kastrati, W. Koch, et al. (2000) HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost 83 559-562.
239. M. Senti, C. Aubo and M. Bosch (1998) The relationship between smoking and triglyceride-rich lipoproteins is modulated by genetic variation in the glycoprotein IIIa gene. Metabolism 47 1040-1041.
240. J. Joven, J.M. Simo, E. Vilella, et al. (1998) Lipoprotein (a) and the significance of the association between platelet glycoprotein IIIa polymorphisms and the risk of premature myocardial infarction. Atherosclerosis 140 155-159.
241. M. Senti, C. Aubo, M. Bosch, et al. (1998) Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients. The REGICOR Investigators. Clin Biochem 31 647-651.
242. A. Di Castelnuovo, G. de Gaetano, M.B. Donati, et al. (2001) Platelet glycoprotein receptor IIIa polymorphism PlA1/PlA2 and coronary risk: A meta-analysis. Thromb Haemost 85 626-633.
243. A.H. Wu and G.J. Tsongalis (2001) Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol 87 1361-1366.
244. D.J. Meiklejohn, M.A. Vickers, E.R. Morrison, et al. (2001) In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib. Br J Haematol 112 621-631.
245. L.E. Carlsson, A. Greinacher, C. Spitzer, et al. (1997) Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa) , von Willebrand factor (GPIb/IX) , and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke 28 1392-1395.
246. M.L. van Goor, G.E. Gomez, G.J. Brouwers, et al. (2002) PLA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIa in young patients with cryptogenic TIA or ischemic stroke. Thromb Res 108 63-65.
247. K.R. Wagner, W.H. Giles, C.J. Johnson, et al. (1998) Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: The Stroke Prevention in Young Women Study. Stroke 29 581-585.
248. A.M. Carter, A.J. Catto, J.M. Bamford, et al. (1998) Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vasc Biol 18 1124-1131.
249. J.Y. Streifler, N. Rosenberg, A. Chetrit, et al. (2001) Cerebrovascular events in patients with signifi cant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke 32 2753-2758.
250. A. Slowik, T. Dziedzic, W. Turaj, et al. (2004) A2 alelle of GpIIIa gene is a risk factor for stroke caused by largevessel disease in males. Stroke 35 1589-1593.
251. E. Papp, V. Havasi, J. Bene, et al. (2005) Glycoprotein IIIA gene (PlA) Polymorphism and aspirin resistance: Is there any correlation? Ann Pharmacother 39 1013-1018.
252. P.F. Bray, C. Cannon, P. Goldschmidt-Clermont, et al. (1998) The PlA2 genetic alteration in the platelet GPIIb-IIIa receptor and the risk of recurrent events in post myocardial infarction patients taking prava statin. J Invest Med 46 190A.
253. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, et al. (2004) PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation. Blood Coagul Fibrinolysis 15 89-93.
254. D.H. Walter, V. Schachinger, M. Elsner, et al. (2001) Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the PlA2 allele of the platelet glycoprotein IIIa gene. Eur Heart J 22 587-595.
255. C. Bottiger, A. Kastrati, W. Koch, et al. (1999) Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement. Am J Cardiol 84 987-991.
256. A.M. Carter, A.J. Catto, J.M. Bamford, et al. (1999) Association of the platelet glycoprotein IIb HPA-3 polymorphism with survival after acute ischemic stroke. Stroke 30 2606-2611.
257. A.P. Reiner, S.M. Schwartz, P.N. Kumar, et al. (2001) Platelet glycoprotein IIb polymorphism, traditional risk factors and non-fatal myocardial infarction in young women. Br J Haematol 112 632-636.
258. M. Murata, Y. Matsubara, K. Kawano, et al. (1997) Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation 96 3281-3286.
259. R. Gonzalez-Conejero, M.L. Lozano, J. Rivera, et al. (1998) Polymorphisms of platelet membrane glycoprotein Iba associated with arterial thrombotic disease. Blood 92 2771-2776.
260. J. Mikkelsson, M. Perola, A. Penttila, et al. (2001) Platelet glycoprotein Iba HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death. Circulation 104 876-880.
261. V. Afshar-Kharghan, N. Matijevic-Aleksic, C. Ahn, et al. (2004) The variable number of tandem repeat polymorphism of platelet glycoprotein Iba and risk of coronary heart disease. Blood 103 963-965.
262. M.C. Ozelo, A.F. Origa, F.J. Aranha, et al. (2004) Platelet glycoprotein Iba polymorphisms modulate the risk for myocardial infarction. Thromb Haemost 92 384-386.
263. S.A. Croft, K.K. Hampton, M.E. Daly, et al. (2000) Kozak sequence polymorphism in the platelet GPIbalpha gene is not asso ciated with risk of myocardial infarction. Blood 95 2183-2184.
264. C. Meisel, V. Afshar-Kharghan, I. Cascorbi, et al. (2001) Role of Kozak sequence polymorphism of platelet glycoprotein Ibalpha as a risk factor for coronary artery disease and catheter interventions. J Am Coll Cardiol 38 1023-1027.
265. D. Kenny, C. Muckian, D.J. Fitzgerald, et al. (2002) Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients. J Thromb Thrombolysis 13 13-19.
266. H. Douglas, K. Michaelides, D.A. Gorog, et al. (2002) Platelet membrane glycoprotein Ibalpha gene-5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis. Heart 87 70-74.
267. R.I. Baker, J. Eikelboom, E. Lofthouse, et al. (2001) Platelet glycoprotein Iba Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 98 36-40.
268. A. Sonoda, M. Murata, Y. Ikeda, et al. (2001) Stroke and platelet glycoprotein Ibalpha polymorphisms. Thromb Haemost 85 573-574.
269. K. Hsieh, M. Funk, M. Schillinger, et al. (2004) Vienna Stroke Registry. Impact of the platelet glycoprotein Iba Kozak polymorphism on the risk of ischemic cerebrovascular events: A case-control study. Blood Coagul Fibrinolysis 15 469-473.
270. K. Moshfegh, W.A. Wuillemin, M. Redondo, et al. (1999) Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: A case-control study. Lancet 353 351-354.
271. A.P. Reiner, P.N. Kumar, S.M. Schwartz, et al. (2000) Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 31 1628-1633.
272. S. Santoso, T.J. Kunicki, H. Kroll, et al. (1999) Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 93 2449-2453.
273. L.E. Carlsson, S. Santoso, C. Spitzer, et al. (1999) The a2 gene coding sequence T807/A873 of the platelet collagen receptor integrin a2b1 might be a genetic risk factor for the development of stroke in younger patients. Blood 93 3583-3586.
274. S.A. Croft, K.K. Hampton, J.A. Sorrell, et al. (1999) The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk factor for myocardial infarction. Br J Haematol 106 771-776.
275. M. Roest, J.D. Banga, D.E. Grobbee, et al. (2000) Homozygosity for 807 T polymorphism in a2 subunit of platelet a2b1 is associated with increased risk of cardiovascular mortality in high-risk women. Circulation 102 1645-1650.
276. N. von Beckerath, W. Koch, J. Mehilli, et al. (2000) Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting. Blood 95 3297-3301.
277. H. Kroll, A. Gardemann, A. Fechter, et al. (2000) The impact of the glycoprotein Ia collagen receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction. Thromb Haemost 83 392-396.
278. R.Y. Zee, N.R. Cook, S. Cheng, et al. (2004) Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: A population-based, prospective genetic analysis. Hum Mol Genet 13 389-396.
279. T.E. Warkentin (1999) Heparin-induced thrombocytopenia: A ten-year retrospective. Annu Rev Med 50 129-147.
280. T.E. Warkenti (1997) Heparin-induced thrombocytopenia. Pathogenesis, frequency, avoidance and management. Drug Saf 17 325-341.
281. M.P. Reilly, S.M. Taylor, N.K. Hartman, et al. (2000) Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model demonstrates the requirement for human platelet factor 4 and platelet activation through FcgRIIa. Blood 96 221a.
282. C. Bachelot, R. Saffroy, S. Gandrille, et al. (1995) Role of FcgRIIA gene polymorphism in human platelet activation by monoclonal antibodies. Thromb Haemost 74 1557-1563.
283. S.I. Rosenfeld, R.J. Looney, J.P. Leddy, et al. (1985) Human platelet Fc receptor for immunoglobulin G. Identifi-cation as a 40,000-molecular-weight membrane protein shared by monocytes. J Clin Invest 76 2317-2322.
284. R.E. Worthington, R.C. Carroll and C. Boucheix (1990) Platelet activation by CD9 monoclonal antibodies is mediated by the FcgII receptor. Br J Haematol 74 216-222.
285. G.P. Anderson and C.L. Anderson (1990) Signal transduction by the platelet Fc receptor. Blood 76 1165-1172.
286. A. Poole, J.M. Gibbins, M. Turner, et al. (1997) The Fc receptor g-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 16 2333-2341.
287. B.S. Gross, J.R. Lee, J.L. Clements, et al. (1999) Tyrosine phosphorylation of SLP-76 is downstream of Syk following stimulation of the collagen receptor in platelets. J Biol Chem 274 5963-5971.
288. G. Arepally, S.E. McKenzie, X.M. Jiang, et al. (1997) FcgRIIA H/R 131 polymorphism, subclass-specific IgG antiheparin/ platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis. Blood 89 370-375.
289. L.E. Carlsson, S. Santoso, G. Baurichter, et al. (1998) Heparin-induced thrombocytopenia: New insights into the impact of the FcgRIIa-R-H131 polymorphism. Blood 92 1526-1531.
290. E. Ollikainen, J. Mikkelsson, M. Perola, et al. (2004) Platelet membrane collagen receptor glycoprotein VI polymorphism is associated with coronary thrombosis and fatal myocardial infarction in middle-aged men. Atherosclerosis 176 95-99.
291. S. Takagi, N. Iwai, S. Baba, et al. (2002) A GPVI polymorphism is a risk factor for myocardial infarction in Japanese. Atherosclerosis 165 397-398.
292. V.J. Cole, J.M. Staton, J.W. Eikelboom, et al. (2003) Collagen platelet receptor polymorphisms integrin alpha-2beta1 C807T and GPVI Q317L and risk of ischemic stroke. J Thromb Haemost 1 963-970.
293. E. Arnaud, O. Poirier, M. Aiach, et al. (2000) The.5061/D polymorphism of the thrombin receptor (PAR-1) gene is not related to myocardial infarction in the ECTIM study. The Étude Cas-Temoins de l'Infarctus du Myocarde. MONICA Members Group. Thromb Haemost 84 722-723.
294. P. Fontan, P. Gaussem, M. Aiach, et al. (2003) P2Y12 H2 haplotype is associated with peripheral arterial disease: A case-control study. Circulation 108 2971-2973.
295. E.J. Topol, J. McCarthy, S. Gabriel, et al. (2001) Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 104 2641-2644.
296. Y. Yamada, H. Izawa, S. Ichihara, et al. (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347 1916-1923.
297. S.M. Boekholdt, M.D. Trip, R.J. Peters, et al. (2002) Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 22 e24-e27.
298. S. Yamada, H. Akita, K. Kanazawa, et al. (2000) T102C polymorphism of the serotonin (5-HT) 2A receptor gene in patients with non-fatal acute myocardial infarction. Atherosclerosis 150 143-148.
299. T. Arinami, T. Ohtsuki, K. Yamakawa-Kobayashi, et al. (1999) A synergistic effect of serotonin transporter gene polymorphism and smoking in association with CHD. Thromb Haemost 81 853-856.
300. F. Fumeron, D. Betoulle, V. Nicaud, et al. (2002) Serotonin transporter gene polymorphism and myocardial infarction: Étude Cas-Temoins de l'Infarctus du Myocarde (ECTIM). Circulation 105 2943-2945.
301. E. Coto, J.R. Reguero, V. Alvarez, et al. (2003) 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. Clin Sci (Lond) 104 241-245.
302. K. Wenzel, G. Baumann and S.B. Felix (1999) The homozygous combination of Leu125Val and Ser563Asn polymorphisms in the PECAM1 (CD31) gene is associated with early severe coronary heart disease. Hum Mutat 14 545.
303. A. Gardemann, A. Knapp, N. Katz, et al. (2000) No evidence for the CD31 C/G gene polymorphism as an independent risk factor of coronary heart disease. Thromb Haemost 83 629.
304. F.C. Song, A.H. Chen, X.M. Tang, et al. (2003) Association of platelet endothelial cell adhesion molecule-1 gene polymorphism with coronary heart disease. Di Yi Jun Yi Da Xue Xue Bao 23 156-158.
305. H. Wei, L. Fang, S.H. Chowdhury, et al. (2004) Plateletendothelial cell adhesion molecule-1 gene polymorphism and its soluble level are associated with severe coronary artery stenosis in Chinese Singaporean. Clin Biochem 37 1091-1097.
306. T. Sasaoka, A. Kimura, S.A. Hohta, et al. (2001) Polymorphisms in the platelet-endothelial cell adhesion molecule-1 (PECAM-1) gene, Asn563Ser and Gly670Arg, associated with myocardial infarction in the Japanese. Ann NY Acad Sci 947 259-269.
307. F. Listi, G. Candore, D. Lio, et al. (2004) Association between platelet endothelial cellular adhesion molecule 1 (PECAM-1/CD31) polymorphisms and acute myocardial infarction: A study in patients from Sicily. Eur J Immunogenet 31 175-178.
308. T.J. Kunicki, A.B. Federici, D.R. Salomon, et al. (2004) An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees. Blood 104 2359-2367.
309. P.J. Di Paola J., A.B. Federici, P.M. Mannucci, et al. (1999) Low platelet a2b1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 93 3578-3582.
310. J. Pereira, T. Quiroga, M.E. Pereira, et al. (2003) Platelet membrane glycoprotein polymorphisms do not influence the clinical expressivity of von Willebrand disease type 1. Thromb Haemost 90 1135-1140.
311. E.V. Potapov, S. Ignatenko, B.A. Nasseri, et al. (2004) Clinical significance of PlA polymorphism of platelet GP IIb/IIIa receptors during long-term VAD support. Ann Thorac Surg 77 869-874.
312. F.F. O'Connor, D.C. Shields, A. Fitzgerald, et al. (2001) Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes. Blood 98 3256-3260.
313. J.A. Iniesta, R. Gonzalez-Conejero, C. Piqueras, et al. (2004) Platelet GP IIIa polymorphism HPA-1 (PlA) protects against subarachnoid hemorrhage. Stroke 35 2282-2286.
314. K. Ghosh, S. Nair, B. Kulkarni, et al. (2003) Milder bleeding tendency in Glanzmann's thrombasthenia patients inheriting HPA-1b in the homozygous state. J Thromb Haemost 1 2255-2256.
315. S.R. Steinhubl, J.S. Varanasi and L. Goldberg (2003) Determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 42 1336-1337.
316. P.A. Gum, K. Kottke-Marchant, E.D. Poggio, et al. (2001) Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88 230-235.
317. M.R. Buchanan and S.J. Brister (1995) Individual variation in the effects of ASA on platelet function: Implications for the use of ASA clinically. Can J Cardiol 11 221-227.
318. A. Hillarp, B. Palmqvist, S. Lethagen, et al. (2003) Mutations within the cyclooxygenase-1 gene in aspirin nonresponders with recurrence of stroke. Thromb Res 112 275-283.
319. A. Undas, K. Brummel, J. Musial, et al. (2001) Pl (A2) polymorphism of beta (3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 104 2666-2672.
320. W.C. Lau, P.A. Gurbel, P.B. Watkins, et al. (2004) Contribution of hepatic cytochrome P4503A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation 109 166-171.
321. N. von Beckerath, O. von Beckerath, W. Koch, et al. (2005) P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose. Blood Coagul Fibrinolysis 16 199-204.
322. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, et al. (2004) 807 C/T polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment. Blood Coagul Fibrinolysis 15 427-433.
323. W.C. Lau, L.A. Waskell, P.B. Watkins, et al. (2003) Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: A new drug-drug interaction. Circulation 107 32-37.
324. C. Bihour, C. Durrieu-Jais, L. Macchi, et al. (1999) Expression of markers of platelet activation and the interpatient variation in response to abciximab. Arterioscler Thromb Vasc Biol 19 212-219.
325. M.B. Holmes, B.E. Sobel and D.J. Schneider (1999) Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjects. Am J Cardiol 84 203-207.
326. M. Rozalski, M. Boncler, B. Luzak, et al. (2005) Genetic factors underlying differential blood platelet sensitivity to inhibitors. Pharmacol Rep 57 1-13.
327. G.L. Wheeler, G.A. Braden, P.F. Bray, et al. (2002) Reduced inhibition by abciximab in platelets with the PlA2 polymorphism. Am Heart J 143 76-82.
328. M.A. Boncler, J. Golanski, R. Paczuski, et al. (2002) Polymorphisms of glycoprotein Ib affect the inhibition by aurintricarboxylic acid of the von Willebrand factor dependent platelet aggregation. J Mol Med 80 796-801.
329. P.F. Bray, C.P. Cannon, P. Goldschmidt-Clermont, et al. (2001) The platelet PlA2 and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol 88 347-352.
330. I.B. Borecki and B.K. Suarez (2001) Linkage and association: Basic concepts. Adv Genet 42 45-66.
331. D.A. Hinds, L.L. Stuve, G.B. Nilsen, et al. (2005) Whole-genome patterns of common DNA variation in three human populations. Science 307 1072-1079.
332. A.G. Clark (2004) The role of haplotypes in candidate gene studies. Genet Epidemiol 27 321-333.
333. D.C. Crawford and D.A. Nickerson (2005) Defi nition and clinical importance of haplotypes. Annu Rev Med 56 303-320.
334. H.O. Kim, Y. Jin, T.S. Kickler, et al. (1995) Gene frequencies of the fi ve major human platelet antigens in African American, white, and Korean populations. Transfusion 35 863-867.
335. S. Kekomaki, J. Partanen and R. Kekomaki (1995) Platelet alloantigens HPA-1,-2,-3,-5 and-6b in Finns. Transfus Med 5 193-198.
336. Y. Merieux, M. Debost, J. Bernaud, et al. (1997) Human platelet antigen frequencies of platelet donors in the French population determined by polymerase chain reaction with sequence-specific primers. Pathol Biol (Paris ) 45 697-700.
337. S. Simsek, N.M. Faber, P.M. Bleeker, et al. (1993) Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA (allele-specific restriction enzyme) analysis. Blood 81 835-840.
338. S. Santoso, S. Santoso, V. Kiefel, et al. (1993) Frequency of platelet-specific antigens among Indonesians. Transfusion 33 739-741.
339. S. Tanaka, A. Taniue, N. Nagao, et al. (1995) Simultaneous DNA typing of human platelet antigens 2, 3 and 4 by an allele-specific PCR method. Vox Sang 68 225-230.
340. H. Morita, H. Kurihara, Y. Imai, et al. (2001) Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and myocardial infarction in Japanese. An approach entailing melting curve analysis with specific fluorescent hybridization probes. Thromb Haemost 85 226-230.
341. T. Ito, F. Ishida, S. Shimodaira, et al. (1999) Polymorphisms of platelet membrane glycoprotein Iba and plasma von Willebrand factor antigen in coronary artery disease. Int J Hematol 70 47-51.